Ligand Pharmaceuticals Inc. (LGND)

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011 - 1994
Revenue	277.13	186.42	120.28	251.45	141.1	108.97	71.91	64.54	48.97	31.39	Upgrade
Revenue Growth (YoY)	48.66%	54.98%	-52.16%	78.21%	29.48%	51.53%	11.43%	31.78%	56.03%	4.50%	Upgrade
Cost of Revenue	62.18	30.42	11.35	6.34	5.37	5.57	5.81	9.14	5.73	3.6	Upgrade
Gross Profit	214.96	156	108.94	245.12	135.74	103.4	66.11	55.4	43.24	27.79	Upgrade
Selling, General & Admin	57.48	64.44	41.88	37.73	28.65	27.65	25.4	22.57	17.98	15.78	Upgrade
Research & Development	69.01	59.39	55.91	27.86	26.89	21.22	11.01	9.75	9.27	10.79	Upgrade
Other Operating Expenses	9.57	6.33	-795.93	15.79	12.12	10.64	2.38	3.46	1.04	1.02	Upgrade
Operating Expenses	136.06	130.16	-698.14	81.39	67.66	59.52	38.78	35.78	28.3	27.59	Upgrade
Operating Income	78.9	25.85	807.08	163.73	68.08	43.89	27.33	19.63	14.94	0.19	Upgrade
Interest Expense / Income	19.63	27.42	35.75	48.28	13.46	12.84	11.8	4.86	2.08	2.92	Upgrade
Other Expense / Income	11.97	8.96	-25.31	-57.88	-2.62	22.35	-22.18	2.33	1.07	-1.01	Upgrade
Pretax Income	47.3	-10.54	796.64	173.33	57.23	8.69	37.71	12.43	11.79	-1.72	Upgrade
Income Tax	-9.84	-7.55	167.34	30.01	44.68	10.33	-192.12	0.41	0.37	-1.19	Upgrade
Net Income	57.14	-2.99	629.3	143.32	12.56	-1.64	229.82	12.02	11.42	-0.53	Upgrade
Net Income Common	57.14	-2.99	629.3	143.32	12.56	-1.64	229.82	12.02	11.42	-0.53	Upgrade
Net Income Growth	-	-	339.09%	1041.45%	-	-	1811.38%	5.29%	-	-	Upgrade
Shares Outstanding (Basic)	17	16	19	21	21	21	20	20	20	20	Upgrade
Shares Outstanding (Diluted)	17	16	20	24	23	21	21	21	21	20	Upgrade
Shares Change	6.55%	-18.08%	-17.91%	2.50%	12.72%	-1.87%	-0.96%	3.32%	4.49%	0.71%	Upgrade
EPS (Basic)	3.44	-0.18	33.13	6.77	0.60	-0.08	11.61	0.59	0.56	-0.03	Upgrade
EPS (Diluted)	3.31	-0.18	31.85	5.96	0.53	-0.08	10.83	0.56	0.55	-0.03	Upgrade
EPS Growth	-	-	434.40%	1024.53%	-	-	1833.93%	1.82%	-	-	Upgrade
Free Cash Flow Per Share	4.24	3.18	-1.68	8.66	4.44	1.98	1.90	0.96	0.82	-0.02	Upgrade
Gross Margin	77.60%	83.70%	90.60%	97.50%	96.20%	94.90%	91.90%	85.80%	88.30%	88.50%	Upgrade
Operating Margin	28.50%	13.90%	671.00%	65.10%	48.20%	40.30%	38.00%	30.40%	30.50%	0.60%	Upgrade
Profit Margin	20.60%	-1.60%	523.20%	57.00%	8.90%	-1.50%	319.60%	18.60%	23.30%	-1.70%	Upgrade
Free Cash Flow Margin	25.50%	27.60%	-26.50%	72.80%	66.20%	37.80%	52.30%	30.30%	34.20%	-1.30%	Upgrade
Effective Tax Rate	-20.80%	71.67%	21.01%	17.31%	78.06%	118.82%	-509.47%	3.30%	3.17%	69.32%	Upgrade
EBITDA	117.87	44.85	876.12	236.32	82.41	32.82	52.14	19.95	16.53	3.93	Upgrade
EBITDA Margin	42.50%	24.10%	728.40%	94.00%	58.40%	30.10%	72.50%	30.90%	33.80%	12.50%	Upgrade
Depreciation & Amortization	50.95	27.97	43.73	14.72	11.71	11.29	2.63	2.66	2.66	2.73	Upgrade
EBIT	66.92	16.88	832.38	221.61	70.69	21.53	49.51	17.29	13.87	1.21	Upgrade
EBIT Margin	24.10%	9.10%	692.00%	88.10%	50.10%	19.80%	68.80%	26.80%	28.30%	3.80%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).